Radiation promotes invasiveness of non-small-cell lung cancer cells through granulocyte-colony-stimulating factor

Oncogene

Volumn 34, Issue 42, 2015, Pages 5372-5382

  Cui, Y H ^a   Suh, Y ^a   Lee, H J ^b   Yoo, K C ^a   Uddin, N ^a   Jeong, Y J ^b   Lee, J S ^c   Hwang, S G ^b   Nam, S Y ^d   Kim, M J ^b   Lee, S J ^a  

^a Hanyang University   (South Korea)

^b Korea Institute of Radiation and Medical Science   (South Korea)

^c Sungkyunkwan University   (South Korea)

^d Korea Hydro & Nuclear Power Co   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BETA CATENIN; CYCLOHEXIMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; STAT3 PROTEIN; VIMENTIN; CTNNB1 PROTEIN, HUMAN; JAK1 PROTEIN, HUMAN; JANUS KINASE 1; STAT3 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL MIGRATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTRACELLULAR SIGNALING; IRRADIATION; LUNG CANCER CELL LINE; MOUSE; NON SMALL CELL LUNG CANCER; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; RADIATION EXPOSURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; CARCINOMA, NON-SMALL-CELL LUNG; LUNG NEOPLASMS; PATHOLOGY; PHYSIOLOGY; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; TUMOR CELL LINE; TUMOR INVASION;

BETA CATENIN; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DOSE FRACTIONATION; EPITHELIAL-MESENCHYMAL TRANSITION; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; JANUS KINASE 1; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; STAT3 TRANSCRIPTION FACTOR;

EID: 84945476445     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.466     Document Type: Article

References (42)

1. Bernier J, Hall EJ, Giaccia A. Radiation oncology: a century of achievements. Nat Rev Cancer 2004; 4: 737-747.
2. Ross GM. Induction of cell death by radiotherapy. Endocr Relat Cancer 1999; 6: 41-44.
3. Dirks PB. Brain tumor stem cells: bringing order to the chaos of brain cancer. J Clin Oncol 2008; 26: 2916-2924.
4. Squatrito M, Brennan CW, Helmy K, Huse JT, Petrini JH, Holland EC. Loss of ATM/Chk2/p53 pathway components accelerates tumor development and contributes to radiation resistance in gliomas. Cancer Cell 2010; 18: 619-629.
5. Acosta JC, Gil J. Senescence: a new weapon for cancer therapy. Trends Cell Biol 2012; 22: 211-219.
6. Burgess AW, Metcalf D. The nature and action of granulocyte-macrophage colony stimulating factors. Blood 1980; 56: 947-958.
7. Metcalf D. The granulocyte-macrophage colony-stimulating factors. Science 1985; 229: 16-22.
8. Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood 1991; 78: 2791-2808.
9. Dale DC, Liles WC, Summer WR, Nelson S. Review: granulocyte colony-stimulating factor-role and relationships in infectious diseases. J Infect Dis 1995; 172: 1061-1075.
10. Diederich K, Sevimli S, Dorr H, Kosters E, Hoppen M, Lewejohann L et al. The role of granulocyte-colony stimulating factor (G-CSF) in the healthy brain: a characterization of G-CSF-deficient mice. J Neurosci 2009; 29: 11572-11581.
11. Teramachi M, Miyamoto N, Yamamoto Y, Sasaka T, Nakamura T, Kitamura F. A case of large cell carcinoma of the lung which is suspected of producing granulocyte colony-stimulating factor. Nihon Kyobu Shikkan Gakkai zasshi 1992; 30: 1327-1332.
12. Watanabe M, Ono K, Ozeki Y, Tanaka S, Aida S, Okuno Y. Production of granulocyte-macrophage colony-stimulating factor in a patient with metastatic chest wall large cell carcinoma. Jpn J Clin Oncol 1998; 28: 559-562.
13. Pylayeva-Gupta Y, Lee KE, Hajdu CH, Miller G, Bar-Sagi D. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell 2012; 21: 836-847.
14. Kowanetz M, Wu X, Lee J, Tan M, Hagenbeek T, Qu X, et al. Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes. Proc Natl Acad Sci USA 2010; 107: 21248-21255.
15. Uemura Y, Kobayashi M, Nakata H, Kubota T, Saito T, Bandobashi K et al. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on lung cancer: roles of cyclooxygenase-2. Oncol Rep 2007; 17: 955-961.
16. Young MR, Charboneau S, Lozano Y, Djordjevic A, Young ME. Activation of the protein kinase a signal transduction pathway by granulocyte-macrophage colony-stimulating factor or by genetic manipulation reduces cytoskeletal organization in Lewis lung carcinoma variants. Int J Cancer 1994; 56: 446-451.
17. Uemura Y, Kobayashi M, Nakata H, Harada R, Kubota T, Taguchi H. Effect of serum deprivation on constitutive production of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells. Int J Cancer 2004; 109: 826-832.
18. Mroczko B, Szmitkowski M. Hematopoietic cytokines as tumor markers. Clin Chem Lab Med: CCLM/FESCC 2004; 42: 1347-1354.
19. Mroczko B, Szmitkowski M, Czygier M. Granulocyte colony stimulating factor (G-CSF) in diagnosis and monitoring of non-small-cell lung cancer (NSCLC). Pol Arch Med Wewn 2000; 103: 163-168.
20. Marino VJ, Roguin LP. The granulocyte colony stimulating factor (G-CSF) activates Jak/STAT and MAPK pathways in a trophoblastic cell line. J Cell Biochem 2008; 103: 1512-1523.
21. Novak U, Ward AC, Hertzog PJ, Hamilton JA, Paradiso L. Aberrant activation of JAK/STAT pathway components in response to G-CSF, interferon-alpha/beta and interferon-gamma in NFS-60 cells. Growth factors 1996; 13: 251-260.
22. Huber MA, Azoitei N, Baumann B, Grunert S, Sommer A, Pehamberger H et al. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 2004; 114: 569-581.
23. Wang Z, Li Y, Kong D, Sarkar FH. The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. Curr Drug Targets 2010; 11: 745-751.
24. Jiang YG, Luo Y, He DL, Li X, Zhang LL, Peng T et al. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha. Int J Urol 2007; 14: 1034-1039.
25. Sanchez-Tillo E, de Barrios O, Siles L, Cuatrecasas M, Castells A, Postigo A. Beta-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness. Proc Natl Acad Sci USA 2011; 108: 19204-19209.
26. Prise KM, O'Sullivan JM. Radiation-induced bystander signalling in cancer therapy. Nat Rev Cancer 2009; 9: 351-360.
27. Multhoff G, Radons J. Radiation, inflammation, and immune responses in cancer. Front Oncol 2012; 2: 58.
28. Kawamoto A, Yokoe T, Tanaka K, Saigusa S, Toiyama Y, Yasuda H et al. Radiation induces epithelial-mesenchymal transition in colorectal cancer cells. Oncol Rep 2012; 27: 51-57.
29. Yan S, Wang Y, Yang Q, Li X, Kong X, Zhang N et al. Low-dose radiation-induced epithelial-mesenchymal transition through NF-kappaB in cervical cancer cells. Int J Oncol 2013; 42: 1801-1806.
30. Liu W, Huang YJ, Liu C, Yang YY, Liu H, Cui JG et al. Inhibition of TBK1 attenuates radiation-induced epithelial-mesenchymal transition of A549 human lung cancer cells via activation of GSK-3beta and repression of ZEB1. Lab Invest 2014; 94: 362-370.
31. Park BK, Zhang H, Zeng Q, Dai J, Keller ET, Giordano T et al. NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat Med 2007; 13: 62-69.
32. Uemura Y, Kobayashi M, Nakata H, Kubota T, Bandobashi K, Saito T et al. Effects of GM-CSF and M-CSF on tumor progression of lung cancer: roles of MEK1/ERK and AKT/PKB pathways. Int J Mol Med 2006; 18: 365-373.
33. Su S, Liu Q, Chen J, Chen J, Chen F, He C et al. A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer Cell 2014; 25: 605-620.
34. Looyenga BD, Hutchings D, Cherni I, Kingsley C, Weiss GJ, Mackeigan JP. STAT3 is activated by JAK2 independent of key oncogenic driver mutations in non-small cell lung carcinoma. PLoS One 2012; 7: e30820.
35. Jiang R, Jin Z, Liu Z, Sun L, Wang L, Li K. Correlation of activated STAT3 expression with clinicopathologic features in lung adenocarcinoma and squamous cell carcinoma. Mol Diagn Ther 2011; 15: 347-352.
36. Liu RY, Zeng Y, Lei Z, Wang L, Yang H, Liu Z et al. JAK/STAT3 signaling is required for TGF-beta-induced epithelial-mesenchymal transition in lung cancer cells. Int J Oncol 2014; 44: 1643-1651.
37. Wendt MK, Balanis N, Carlin CR, Schiemann WP. STAT3 and epithelial-mesenchymal transitions in carcinomas. Jak-Stat 2014; 3: e28975.
38. Rokavec M, Oner MG, Li H, Jackstadt R, Jiang L, Lodygin D et al. IL-6 R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. J Clin Invest 2014; 124: 1853-1867.
39. Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell 2012; 149: 1192-1205.
40. Fang D, Hawke D, Zheng Y, Xia Y, Meisenhelder J, Nika H et al. Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. J Biol Chem 2007; 282: 11221-11229.
41. Wang WC, Tsai JJ, Kuo CY, Chen HM, Kao SH. Non-proteolytic house dust mite allergen, Der p 2, upregulated expression of tight junction molecule claudin-2 associated with Akt/GSK-3beta/beta-catenin signaling pathway. J Cell Biochem 2011; 112: 1544-1551.
42. Zhang J, Shemezis JR, McQuinn ER, Wang J, Sverdlov M, Chenn A. AKT activation by N-cadherin regulates beta-catenin signaling and neuronal differentiation during cortical development. Neural Dev 2013; 8: 7.